Table 1.

Patient baseline characteristics (N = 20)

Age	66 ± 10.5 years
Female sex	8 (40%)
Edoxaban dose	60 mg daily: 15 (75%) 30 mg daily: 5 (25%)
Body weight	80.5 ± 20.11 kg
Body Mass Index (BMI)	27.0 ± 5.87 kg/m2
Estimated glomerular filtration rate (CDK-EPI)	74 ± 18.6 mL/min/1.73 m2
Estimated glomerular filtration rate (MDRD)	74 ± 21.5 mL/min/1.73 m2
Estimated glomerular filtration rate (Cockcroft-Gault)	83 ± 26.0 mL/min/1.73 m2
Risk factors
Arterial hypertension	16 (80%)
Hyperlipidemia	7 (35%)
Diabetes mellitus	1 (5%)
History of stroke	20 (100%)
Congestive heart failure	2 (10%)
Coronary heart disease	7 (35%)
History of myocardial infarction	5 (25%)
Smoking	4 (20%)
Indication for anticoagulation therapy
Atrial fibrillation (AF)	12 (60%)
Stroke associated with patent foramen ovale	6 (30%)
Embolic stroke of undetermined source (off label)	2 (10%)
Concomitant antiplatelet therapy	4 (20%)

Continuous variables are displayed as mean ± standard deviation

Nominal variables are displayed as absolute quantity (percentage)